Crossmark

SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort

Crossref DOI link: https://doi.org/10.1186/s12916-024-03351-w

Published Online: 2024-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dietz, Elisabeth

Pritchard, Emma

Pouwels, Koen

Ehsaan, Muhammad

Blake, Joshua

Gaughan, Charlotte

Haduli, Eric

Boothe, Hugh

Vihta, Karina-Doris

Peto, Tim

Stoesser, Nicole

Matthews, Philippa

Taylor, Nick

Diamond, Ian

Studley, Ruth

Rourke, Emma

Birrell, Paul

De Angelis, Daniela

Fowler, Tom

Watson, Conall

Eyre, David

House, Thomas

Walker, Ann Sarah
License Information

Text and Data Mining valid from 2024-03-26

Version of Record valid from 2024-03-26
More Information

Article History

Received: 14 November 2023

Accepted: 7 March 2024

First Online: 26 March 2024

Declarations

:

: The study received ethical approval from the South Central Berkshire B Research Ethics Committee (20/SC/0195). Following verbal agreement to participate, a study worker visited each selected household to take written informed consent for individuals aged 2 years and over. For those aged 2–15 years, consent was provided by their parents or carers; those aged 10–15 years also provided written assent.

: Not applicable.

: DWE declares lecture fees from Gilead, outside the submitted work. PCM has received GSK funding support.

Document is current

Any future updates will be listed below